PuSH - Publication Server of Helmholtz Zentrum München: Management of SARS-CoV-2 infection is a major challenge in patients with lymphoid malignancies: Warrants a clear therapeutic strategy.

Navigation

Home

Deutsch

Research

Advanced Search

Browse by ...

... Journal

... Publication Type

... Research Data

... Publication Year

Publication overview

Support & Contact

Contact persons

Help

Data protection

Sahu, T.* ; Verma, H.K. ; Lvks, B.*

Management of SARS-CoV-2 infection is a major challenge in patients with lymphoid malignancies: Warrants a clear therapeutic strategy.

World J. Virol. 11, 204-207 (2022)

Publ. Version/Full Text

DOI

PMC

	Free journal

Abstract
Metrics
Extra information

Patients with lymphoid malignancies are at a higher risk of coronavirus disease 2019 (COVID-19) infection due to their immunocompromised state and results in higher mortality rates in these patients. Anti-CD 20 therapy is one of the leading causes of immunosuppression that worsens in COVID-19 cases. COVID-19 vaccines, on the other hand, appear to be less beneficial to these patients. App-ropriate treatment and recommendations are required for these COVID-19 patients with lymphoid malignancies.

Altmetric

Additional Metrics?

[➜Log in]

Edit extra informations Login

Publication type Article: Journal article

Document type Letter to the Editor

Corresponding Author

Keywords Covid-19 ; Immuno-suppression ; Lymphoid Malignancy ; Lymphoma ; Vaccination

ISSN (print) / ISBN 2220-3249

e-ISSN 2220-3249

Journal World Journal of Virology

Quellenangaben Volume: 11, Issue: 4, Pages: 204-207

Publisher Baishideng Publ.

Non-patent literature Publications

Reviewing status Peer reviewed

Institute(s) Institute of Lung Health and Immunity (LHI)